Animal studies demonstrate that GLP-1 receptor activation influences dopamine signaling in brain regions tied to attention
Taking glutathione in the morning may help prime your system with antioxidant protection before these challenges begin
By stimulating insulin release and inhibiting glucagon, tirzepatide helps stabilize blood sugar levels and reduce the risk of hyperglycemia, insulin resistance, and type 2 diabetes
GLP-1s are non-opioid therapies
Similarly, sibutramine (Meridia), a serotonin and dopamine reuptake inhibitor that works by inducing satiety and increasing energy expenditure 8 , was approved in 1997 against a background of divided opinion on its safety profile because, while effective for weight-loss, it tended to increase blood pressure and pulse rate 6
Setting this up requires significant infrastructure typically only found at specialist Mohs centres